| Metric | FY2021 | FY2020 |
|---|---|---|
| Research and development | $30.7M+28.7% | $23.9M |
| General and administrative | $11.4M+104.4% | $5.6M |
| Total operating expenses | $42.1M+43.0% | $29.4M |
| Loss from operations | -$42.1M-43.0% | -$29.4M |
| Interest expense | -$345K-6.8% | -$323K |
| Other income, net | $119K-40.5% | $200K |
| Net loss | -$42.3M-43.2% | -$29.5M |
| Unrealized loss on available for sale securities | -$184K | — |
| Total comprehensive loss | -$42.5M-43.8% | -$29.5M |
| Net loss per share, basic and diluted | -$1.81+63.3% | -$4.93 |
| Weighted-average shares of common stock outstanding, basic and diluted | 23.36B+289.9% | 5.99B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.